Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements
Review
[키워드] acute respiratory distress syndrome
Admission
Antibiotics
article
association
CAPA
Characteristics
chronic condition
Chronic kidney disease
Comorbidities
concerning
conditions
Corticosteroid
Corticosteroids
Course
COVID
COVID-19
COVID-19-associated pulmonary aspergillosis
Critically ill patient
diabetes
Diagnosis
diagnostic
disease
element
environmental factors
epidemiological
evaluate
Factor
Factors
feature
hospital
Host
ICU
ICU patient
Immunomodulatory agents
influenza infection
intensive care
intensive care unit
invasive
Invasive pulmonary aspergillosis
IPA
Isolation
Liver cirrhosis
management
mechanical ventilation
Non-invasive respiratory support
Obstructive
pandemic
potential risk
Prolonged
Prospective Study
pulmonary disease
reported
respiratory diseases
Reviewing
risk factor
Risk factors
SARS-CoV-2
SARS-CoV2 infection
severe immunosuppression
shifting
Spread
Surveillance
Therapeutic approach
Therapies
therapy
treat
Treatment
Ventilation
[DOI] 10.1186/s13613-021-00923-4 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s13613-021-00923-4 PMC 바로가기 [Article Type] Review